الرئيسية/Mona Nafea/Highlight in the treatment of Rectal cancer

Highlight in the treatment of Rectal cancer

6 يوليو 2023 5 مهارة

عن المشروع

As the third most common malignancy and the second most deadly cancer, colorectal cancer (CRC) induces estimated 1.9 million incidence cases and 0.9 million deaths worldwide in 2020. The incidence of CRC is higher in highly developed countries, and it is increasing in middle- and low-income countries due to westernization. Globally, 60% of cases are diagnosed at ages 50–74 years, and almost 10% occur in adults under 50. By 2040, the number of cases of colorectal cancer is predicted to increase to 3.2 million new cases and 1.6 million deaths https://sway.office.com/cDSy1TBq9aXVbGgA?ref=Link

التقنيات المستخدمة

Rectal cancer treatmentneoadjuvat CCRTP rectal cancersphincter preservationAPRLAR

وسائل الدفع المتاحة

ادفع بأمان وسهولة باستخدام

PayPal
PayPal
VISA
VISA
Mastercard

وسائل سحب الأرباح

اسحب أرباحك بالطريقة الأنسب لك

PayPal
إنستاباي
تحويل بنكي
محفظة إلكترونية
جميع المعاملات مشفّرة وآمنة 100%